Home > Insider Trading > Filing (0001415889-25-008282)

Filing Details

Accession Number:: 0001415889-25-008282
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-17 21:51:08
Reporting Period:: 2024-03-26

Filing Date:: 2025-03-17
Accepted Time:: 2025-03-17 21:51:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1818331	Genedx Holdings Corp.	WGS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1689575	Katherine Stueland	C/O Genedx Holdings Corp. 333 Ludlow St., North Tower, 6Th Floor Stamford CT 06902	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2025-03-13	1,078	$89.44	6,674	No	4	S	Direct
Class A Common Stock	Acquisiton	2025-03-16	18,750	$0.00	25,424	No	4	M	Direct
Class A Common Stock	Disposition	2025-03-17	10,559	$96.71	14,865	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Unit	Acquisiton	2024-03-26	320,000	$0.00	320,000	$0.00
Class A Common Stock	Restricted Stock Unit	Acquisiton	2025-03-15	47,684	$0.00	47,684	$0.00
Class A Common Stock	Restricted Stock Unit	Disposition	2025-03-16	18,750	$0.00	18,750	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
320,000	No	4	A	Direct
47,684	No	4	A	Direct
150,000	No	4	M	Direct

Footnotes

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell tocover" transaction
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.695 to $89.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.30 to $96.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On March 26, 2024, Katherine Stueland was granted an RSU award for 320,000 RSUs. 25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
25% of the underlying restricted stock units each vests annually, commencing on March 15, 2026, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.